Nucleoplasmic calcium regulates cell proliferation through legumain

• Published in: Journal of hepatology 2011-09, Vol.55 (3), p.626-635
• Main Authors: Andrade, Viviane, Guerra, Mateus, Jardim, Camila, Melo, Flavia, Silva, Wamberto, Ortega, Jose M, Robert, Marie, Nathanson, Michael H, Leite, Fatima
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Calcium - metabolism; Calcium Signaling - physiology; Carcinoma, Hepatocellular - metabolism; Cell Nucleus - metabolism; Cell Proliferation; Cysteine Endopeptidases - genetics; Cysteine Endopeptidases - metabolism; Cysteine Endopeptidases - physiology; G2 Phase Cell Cycle Checkpoints; Gastroenterology and Hepatology; Gastroenterology. Liver. Pancreas. Abdomen; Gene Knockdown Techniques; Hepatocellular carcinoma; Hepatocytes - metabolism; Humans; Legumain; Liver. Biliary tract. Portal circulation. Exocrine pancreas; Medical sciences; Nuclear calcium; RNA, Messenger - metabolism; Tumor Cells, Cultured; Tumors
• ISSN: 0168-8278; 1600-0641
• DOI: 10.1016/j.jhep.2010.12.022

Background & Aims Nucleoplasmic Ca2+ regulates cell growth in the liver, but the proteins through which this occurs are unknown. Methods We used Rapid Subtraction Hybridization (RaSH) to subtract genes in SKHep1 liver cells expressing the Ca2+ buffer protein parvalbumin (PV) targeted to the nucleus, from genes in cells expressing a mutated form of nuclear-targeted PV which has one of two Ca2+ -binding sites inactivated. The subtraction permitted the selection of genes whose expression was affected by a small alteration in nuclear Ca2+ concentration. Results The asparaginyl endopeptidase legumain (LGMN) was identified in this screening. When Ca2+ was buffered in the nucleus of SKHep1 cells, LGMN mRNA was decreased by 97%, in part by a transcriptional mechanism, and decreased expression at the protein level was observed by immunoblot and immunofluorescence. Treatment with hepatocyte growth factor increased LGMN expression. Knockdown of LGMN by siRNA decreased proliferation of SKHep1 cells by ∼50% as measured both by BrdU uptake and mitotic index, although an inhibitor of LGMN activity did not affect BrdU incorporation. A significant reduction in the fraction of cells in G2/M phase was seen as well. This was associated with increases in the expression of cyclins A and E. Furthermore, LGMN expression was increased in hepatocellular carcinoma cells relative to normal hepatocytes in the same specimens. Conclusions These findings suggest a new role for LGMN and provide evidence that nuclear Ca2+ signals regulate cell proliferation in part through the modulation of LGMN expression. Increased expression of LGMN may be involved in liver carcinogenesis.